Cargando…
Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360903/ https://www.ncbi.nlm.nih.gov/pubmed/30774242 http://dx.doi.org/10.4103/joacp.JOACP_155_18 |
| _version_ | 1783392605284859904 |
|---|---|
| author | Tive, Leslie A. Viktrup, Lars Shelton, David |
| author_facet | Tive, Leslie A. Viktrup, Lars Shelton, David |
| author_sort | Tive, Leslie A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6360903 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63609032019-02-17 Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” Tive, Leslie A. Viktrup, Lars Shelton, David J Anaesthesiol Clin Pharmacol Letters to Editor Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6360903/ /pubmed/30774242 http://dx.doi.org/10.4103/joacp.JOACP_155_18 Text en Copyright: © 2019 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to Editor Tive, Leslie A. Viktrup, Lars Shelton, David Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” |
| title | Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” |
| title_full | Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” |
| title_fullStr | Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” |
| title_full_unstemmed | Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” |
| title_short | Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis” |
| title_sort | response to: “tanezumab: therapy targeting nerve growth factor in pain pathogenesis” |
| topic | Letters to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360903/ https://www.ncbi.nlm.nih.gov/pubmed/30774242 http://dx.doi.org/10.4103/joacp.JOACP_155_18 |
| work_keys_str_mv | AT tivelesliea responsetotanezumabtherapytargetingnervegrowthfactorinpainpathogenesis AT viktruplars responsetotanezumabtherapytargetingnervegrowthfactorinpainpathogenesis AT sheltondavid responsetotanezumabtherapytargetingnervegrowthfactorinpainpathogenesis |